SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-012605
Filing Date
2024-01-23
Accepted
2024-01-23 08:00:00
Documents
16
Period of Report
2024-01-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d731182d8k.htm   iXBRL 8-K 33566
2 EX-10.1 d731182dex101.htm EX-10.1 102302
3 EX-99.1 d731182dex991.htm EX-99.1 12602
7 GRAPHIC g731182g0123055540862.jpg GRAPHIC 2988
8 GRAPHIC g731182g0123062634417.jpg GRAPHIC 3347
  Complete submission text file 0001193125-24-012605.txt   312668

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA lnth-20240118.xsd EX-101.SCH 2854
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20240118_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20240118_pre.xml EX-101.PRE 11264
10 EXTRACTED XBRL INSTANCE DOCUMENT d731182d8k_htm.xml XML 3355
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36569 | Film No.: 24550502
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)